Physician
Matthew Francis Koscielski, M.D.
According to 2025 Medicare claims, Matthew Koscielski, M.D. (NPI: 1629052543) practices critical care (intensivists) in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from St. Joseph, IN. This provider's primary affiliated billing organization is BEACON MEDICAL GROUP, INC. (NPI: 1821222829; TIN: 351536132) and primary practice location at 46601-1033. Koscielski is affiliated with the CHA ACO, LLC (ACO ID: A2207) and Caravan Health ACO 43 LLC (ACO ID: A4974), participating under the MSSP model.
Koscielski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 3,028 HCPCS/CPT codes, and received $197,505 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,879 prescription claims across 648 beneficiaries totaling $2,655,941 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,302 claims. Open Payments data shows 111 records totaling $4,017. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $321,293 to $197,505. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,244,311 to $2,655,941. For DME billing, reported payments declined steadily, from $186,258 to $60,565.